Vnitr Lek 2006, 52(9):823-826

Atherosclerosis and infection?

K. Zeman
I. interní kardio-angiologická klinika Lékařské fakulty MU a FN u sv. Anny, Brno, přednosta prof. MUDr. Jiří Vítovec, CSc., FESC

Atherosclerosis is guided by chronicle inflammation process. In the last decades of the 20th century, studies considering infection another possible risk factor of atherosclerosis development were written. Helicobacter pylori, Porphyromas gingivalis, some viruses but most frequently Chlamydia pneumonie are infection agens mentioned in these studies. Some of them emphasize also combined infections caused by more pathogenic factors having influence on vascular inflammation. Serological, epidemiological, histological and imunological studies show the pathogenic influence of acute or chronic infections. Many studies selected makrolid antibiotics as treatment in patients with ischaemic heart disease. However, existing experience with antibiotics did not bring clear results. These studies have mentioned the fact antibiotics have not been indicated as treatment in patients with acute or chronic vascular system infliction by atherosclerosis. Since the experimental and clinical research of influence of inflammations on the development of atherosclerosis moved forward a lot, no exact evidence of this complicated pathogenic mechanism was given. It will obviously take some time to confirm whether the relation between infections and artherosclerosis is causal, i.e. initiating the pathogenic process, accelerating it or keeping it alive.

Keywords: atherosclerosis; infection

Received: November 14, 2005; Accepted: April 10, 2006; Published: September 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zeman K. Atherosclerosis and infection? Vnitr Lek. 2006;52(9):823-826.
Download citation

References

  1. Šimon J. K nově objeveným rizikovým faktorům aterosklerózy a ischemické choroby srdeční. Cor Vasa 1998; 40: 323-324.
  2. Saikku P, Leuinomeni M, Mattila K et al. Serological evidence of an association of a novel Chlamydia TWAR with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983-985. Go to original source... Go to PubMed...
  3. Saikku P, Leinonen M, Tenkanen L Chronic Chlamydia pneumoniae infection as a Risk factor for Coronary Heart disease in the Helsinki Heart Study. Ann Int Med 1992; 116: 273-278. Go to original source... Go to PubMed...
  4. Renvert S, Ohlsson S, Persson S et al. Analysis of periodontal risk profiles in adults with or without a history of myocardial infarction. J Clin Periodontol 2004; 31: 19-24. Go to original source... Go to PubMed...
  5. Dodet B. Infection and Atherosclerosis. Amer Heart J 1999; 138: 417-418. Go to original source...
  6. Fong IW Emerging relation between infections disease and coronary artery disease and atherosclerosis. Canadian Med Assoc J 2000; 163: 49-56.
  7. Zeman K, Pospíšil L, Diblíková I et al. Chlamydia pneumoniae a infarkt myokardu. Vnitř Lék 2001; 47: 852-855. Go to PubMed...
  8. Medková Z, Kalousek I, Jarčuška P. Chlamydiové infekce. Praha: Triton 2001.
  9. Gupta S, Camm AJ. Chlamydia pneumoniae and coronary heart disease. BMJ 1997; 314: 1778-1779. Go to original source... Go to PubMed...
  10. Wong YK, Gallagher PJ, Ward ME. Chlamydia pneumonaie and atherosclerosis. Heart 1999; 81: 232-238. Go to original source... Go to PubMed...
  11. Zhu J, Nieto FJ, Horne BD et al. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 2001; 103: 45-51. Go to original source... Go to PubMed...
  12. Ben-Yaakov M, Eshel G, Zaksonski L et al. Prevalence of antibodies to Chlamydia pneumoniae in an Israeli population without clinical evidence of respiratory infection. J Clin Pathol 2002; 55: 355-358. Go to original source... Go to PubMed...
  13. Zhu J, Nieto FJ, Home BD et al. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 2001; 103: 45-51. Go to original source... Go to PubMed...
  14. Mahdi OS, Horne BD, Mullen K et al. Serum immunoglobulin G antibodies to chlamydial heat shock protein 60 but not to human and bacterial homologs are associated with coronary disease. Circulation 2002; 106: 1659-1663. Go to original source... Go to PubMed...
  15. Pospíšil L, Čanderle J, Zeman K et al. Serologické vyšetření u aterosklerózy a jejich cévních komplikací. Epidemiol Mikrobiol Immunol 2003; 52: 142-146.
  16. Danesh J, Whincup P, Walker M et al. Chlamydia pneumoniae IgG titres and coronary heart disease prospective study and meta-analysis. BMJ 2000; 321: 208-213. Go to original source... Go to PubMed...
  17. Pospíšil L, Čanderle J, Štroblová H et al. Protilátky proti proteinu tepelného šoku a dalším antigenům chlamydií u některých chorob ve srovnání s jejich výskytem u dárců krve. Čas Lék Čes 2003; 142: 661-664.
  18. Štercl J. Imunitní systém a jeho fyziologické funkce. Praha: Čes imunolog. spol. 1993: 1-480.
  19. Ošťádal P. Úloha zánětu v patogenezi akutních forem ischemické choroby srdeční. Cor Vasa 1997; 39: 231-234.
  20. Meniconi A, Noll G, Litscher TF Is arteriosclerosis an infectious disease? Schweiz Rundsch Med Prax 1998; 87: 64-74.
  21. Stemme S, Faber B, Holm J et al. T lymphocytes from human atherosclerotic plaques recognize low density lipoprotein. Proc Natl Acad Sci USA 1995; 92: 3893-3897. Go to original source... Go to PubMed...
  22. Haverkate F, Thomptson SG, Pyke SDM et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997; 349: 462-466. Go to original source... Go to PubMed...
  23. Gabay C, Kushner I Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454. Go to original source... Go to PubMed...
  24. Gupta S, Leatham EW, Carington D et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of acute myocardial infarction. Circulation 1997; 96: 404-407. Go to original source... Go to PubMed...
  25. Gurfinkel E, Bozovich G, Beck E et al. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes: The final report of the ROXIS Study. Eur Heart J 1999; 20: 121-127. Go to original source... Go to PubMed...
  26. Neuman FJ, Kastrati A, Miethke T et al. Treatment of Clamydia pneumoniae infection with roxithromycin and efect on neointima proliferation after coronary stent placement (ISAR-3): a randomised double-blind, placebo-controlled trial. Lancet 2001; 357: 2085-2089. Go to original source... Go to PubMed...
  27. O'Conor, CM, Dunne MW, Pfeffer MA et al. Azithromycin for the secondary prevention of coronary heart disease events. The WISARD study: a randomized controlled trial. JAMA 2003; 290: 1359-1466. Go to original source... Go to PubMed...
  28. Pravastatin or Atrovastatin Evaluatio Infection Therapy - Thrombolysis In Myocardial Infarction (PROVE IT-TIMI 22). Ústní sdělení na kongresu Evropské kardiologické společnosti (Europien Society of Cardiology) Cannon CP (Boston, USA) 30. 7. 2004. Mnichov.
  29. Grayston JT, Kronmal RA, Jackson LA et al. Azithromycin for the Secondary Prevention of Coronary Events (ACES). N Engl J Med 2005; 346: 1637-1645. Go to original source... Go to PubMed...
  30. Espinola-Klein Ch, Rupprecht HJ, Blankenberg S et al. Impact of Infectious Burde on Extent and Long-Term Prognosis of Aterosclerosis. Circulation 2002; 105: 14-21. Go to original source... Go to PubMed...
  31. Stone AF, Mendall MA, Kaski JC et al. Effect of Treatment for Chlamydia pneumoniae and Helicobacter pylori on Markers of Inflammation and Cardiac Events in Patients With Acute Coronary Syndromes. South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STATIMA). Circulation 2002; 106: 1219-1223. Go to original source... Go to PubMed...
  32. Chi H, Messas E, Levine RA et al. Interleukin-1 Receptor Signaling Mediates Atherosclerosis Associated With Bacterial Exposure and or a High-Fat Diet in s Murine Apolipoprotein E Heterozygote Model. Circulation 2004; 21: 1678-1685. Go to original source... Go to PubMed...
  33. Tiong AY, Brieger D. Inflamation and coronary artery disease. Am Heart J 2005; 150: 11-18. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.